Noncompaction cardiomyopathy medical therapy: Difference between revisions
Jump to navigation
Jump to search
New page: {{Noncompaction cardiomyopathy}} {{CMG}} ==Overview== ==References== {{Reflist|2}} Category:Cardiology Category:Overview complete {{WH}} {{WS}} |
No edit summary |
||
| Line 3: | Line 3: | ||
==Overview== | ==Overview== | ||
Given the risk of [[embolization]], these patients are generally treated with prophylactic [[aspirin]]. | |||
==References== | ==References== | ||
Revision as of 14:43, 3 August 2011
|
Noncompaction Cardiomyopathy Microchapters |
|
Pathophysiology |
|---|
|
Differentiating Noncompaction Cardiomyopathy from other Diseases |
|
Diagnosis |
|
Treatment |
|
Noncompaction cardiomyopathy medical therapy On the Web |
|
Risk calculators and risk factors for Noncompaction cardiomyopathy medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Given the risk of embolization, these patients are generally treated with prophylactic aspirin.